Shilpa Medicare Unit VI Bengaluru facility registered with Ministry of Health, UAE
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
Plans underway to expand screening capacity by 50% for greater accessibility
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
Conceptualized, designed, and manufactured in India for the world, Cios Fit is a mobile C-arm designed for demanding multidisciplinary environments in busy operating rooms
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
Subscribe To Our Newsletter & Stay Updated